28110669|t|In vitro screening and in silico validation revealed key microbes for higher production of significant therapeutic enzyme l-asparaginase
28110669|a|l-asparaginase is an enzyme of medical prominence and reputable as a chemotherapeutic agent. It also has immense potential to cure autoimmune and infectious diseases. The vast application of this enzyme in healthcare sector increases its market demand. However, presently the huge market demand is not achieved completely. This serves the basis to explore better producer microbial strains to bridge the gap between huge demand and supply of this therapeutic enzyme. The present study deals with the successful screening of potent microorganisms producing l-asparaginase. 47 microorganisms were screened including bacteria, fungi, and yeasts. Among all, Penicillium lilacinum showed the highest enzyme activity i.e., 39.67 IU/ml. Shigella flexneri has 23.21 IU/ml of enzyme activity (highest among all the bacterial strain tested). Further, the 3-D structure of l-asparaginase from higher producer strains was developed and validated in silico for its activity. l-asparagine (substrate for l-asparaginase) was docked inside the binding pocket of P. lilacinum and S. flexneri. Docking score for the most common substrate l-asparagine is -6.188 (P. lilacinum), -5.576 (S. flexneri) which is quite good. Moreover, the chemical property of the binding pocket revealed that amino acid residues Phe 243, Gln 260, Gly 365, Asp 386 in P. lilacinum and residues Asp 181, Thr 318, Asn 320 in S. flexneri have an important role in H-bonding. The in silico results supports and strengthen the wet lab results. The outcome obtained motivates to take the present study result from lab to industry for the economic / massive production of this enzyme for the diverse therapeutic application.
28110669	0	8	In vitro	T080	C1533691
28110669	9	18	screening	T059	C0807878
28110669	23	32	in silico	T066	C3489666
28110669	33	43	validation	T062	C1519941
28110669	57	65	microbes	T001	C0445623
28110669	70	76	higher	T080	C0205250
28110669	77	87	production	T057	C0033268
28110669	103	121	therapeutic enzyme	T121	C0872370
28110669	122	136	l-asparaginase	T116,T121,T126	C0003993
28110669	137	151	l-asparaginase	T116,T121,T126	C0003993
28110669	158	164	enzyme	T116,T126	C0014442
28110669	168	175	medical	T169	C0205476
28110669	176	186	prominence	T080	C3898777
28110669	206	228	chemotherapeutic agent	T121	C0729502
28110669	250	259	potential	T080	C3245505
28110669	263	267	cure	T077	C1880198
28110669	268	278	autoimmune	T047	C0004364
28110669	283	302	infectious diseases	T047	C0009450
28110669	313	324	application	T169	C4048755
28110669	333	339	enzyme	T116,T126	C0014442
28110669	343	360	healthcare sector	T078	C0525053
28110669	361	370	increases	T169	C0442805
28110669	375	381	market	T169	C0680164
28110669	382	388	demand	T078	C0699784
28110669	418	424	market	T169	C0680164
28110669	425	431	demand	T078	C0699784
28110669	509	526	microbial strains	T001	C0445623
28110669	558	564	demand	T078	C0699784
28110669	584	602	therapeutic enzyme	T121	C0872370
28110669	616	621	study	T062	C2603343
28110669	648	657	screening	T059	C0807878
28110669	668	682	microorganisms	T001	C0445623
28110669	693	707	l-asparaginase	T116,T121,T126	C0003993
28110669	712	726	microorganisms	T001	C0445623
28110669	732	740	screened	T059	C0807878
28110669	751	759	bacteria	T007	C0004611
28110669	761	766	fungi	T004	C0016832
28110669	772	778	yeasts	T004	C0043393
28110669	791	812	Penicillium lilacinum	T004	C0260109
28110669	832	847	enzyme activity	T044	C0243102
28110669	867	884	Shigella flexneri	T007	C0036957
28110669	904	919	enzyme activity	T044	C0243102
28110669	943	959	bacterial strain	T007	C0004611
28110669	982	995	3-D structure	T082	C0026377
28110669	999	1013	l-asparaginase	T116,T121,T126	C0003993
28110669	1026	1042	producer strains	T001	C1518614
28110669	1061	1070	validated	T062	C1519941
28110669	1071	1080	in silico	T066	C3489666
28110669	1089	1097	activity	T044	C0243102
28110669	1099	1111	l-asparagine	T116,T123	C0003995
28110669	1113	1122	substrate	T167	C3891814
28110669	1127	1141	l-asparaginase	T116,T121,T126	C0003993
28110669	1147	1153	docked	T044	C1522290
28110669	1165	1179	binding pocket	T192	C0005456
28110669	1183	1195	P. lilacinum	T004	C0260109
28110669	1200	1211	S. flexneri	T007	C0036957
28110669	1213	1220	Docking	T044	C1522290
28110669	1221	1226	score	T081	C0449820
28110669	1247	1256	substrate	T167	C3891814
28110669	1257	1269	l-asparagine	T116,T123	C0003995
28110669	1281	1293	P. lilacinum	T004	C0260109
28110669	1304	1315	S. flexneri	T007	C0036957
28110669	1352	1369	chemical property	T070	C0243178
28110669	1377	1391	binding pocket	T192	C0005456
28110669	1406	1425	amino acid residues	T116,T121,T123	C0002520
28110669	1426	1429	Phe	T116,T121,T123	C0031453
28110669	1435	1438	Gln	T116,T121,T123	C0017797
28110669	1444	1447	Gly	T116,T121,T123	C0017890
28110669	1453	1456	Asp	T116,T123	C0004015
28110669	1464	1476	P. lilacinum	T004	C0260109
28110669	1481	1489	residues	T116,T121,T123	C0002520
28110669	1490	1493	Asp	T116,T123	C0004015
28110669	1499	1502	Thr	T116,T121,T123	C0040005
28110669	1508	1511	Asn	T116,T123	C0003995
28110669	1519	1530	S. flexneri	T007	C0036957
28110669	1557	1566	H-bonding	T070	C0020276
28110669	1572	1581	in silico	T066	C3489666
28110669	1582	1589	results	T169	C1274040
28110669	1618	1625	wet lab	T073,T093	C0022877
28110669	1626	1633	results	T169	C1274040
28110669	1639	1646	outcome	T169	C1274040
28110669	1686	1691	study	T062	C2603343
28110669	1692	1698	result	T169	C1274040
28110669	1704	1707	lab	T073,T093	C0022877
28110669	1711	1719	industry	T057	C0021267
28110669	1728	1736	economic	T169	C0013557
28110669	1739	1746	massive	T080	C0522501
28110669	1747	1757	production	T057	C0033268
28110669	1766	1772	enzyme	T116,T126	C0014442
28110669	1781	1788	diverse	T080	C1880371
28110669	1789	1800	therapeutic	T169	C0302350
28110669	1801	1812	application	T169	C4048755